Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:e65
doi: 10.1161/01.ATV.0000102520.84030.A1
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bell, A.
Right arrow Articles by Sorisky, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bell, A.
Right arrow Articles by Sorisky, A.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:e65.)
© 2003 American Heart Association, Inc.


Letters to the Editor

TSH Stimulates IL-6 Secretion from Adipocytes in Culture

Andrea Bell; AnneMarie Gagnon; Alexander Sorisky

Department of Medicine and of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa Health Research Institute, Ottawa, Canada


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

Adipocytes secrete interleukin-6 (IL-6), a pro-atherogenic cytokine.1–3 However, regulation of adipocyte IL-6 secretion remains largely unknown. Adipocytes express thyroid-stimulating hormone (TSH) receptors.4–6 Because subclinical hypothyroidism, characterized by an elevated TSH level, is an independent cardiovascular disease (CVD) risk factor,7 we hypothesized that TSH stimulates adipocyte IL-6 secretion.

3T3-F442A (Dr. Howard Green, Harvard University, Boston, Mass)8 and 3T3-L1 (ATCC) cells were grown in DMEM with 10% calf serum in 35-mm dishes. Confluent 3T3-F442A preadipocytes were differentiated in control medium (DMEM with 10% fetal bovine serum [FBS]) with 1 µM insulin for 8 days.9 Confluent 3T3-L1 preadipocytes were differentiated with control medium with 1 µmol/L insulin over 8 days, and 0.25 µmol/L dexamethasone and 0.5 mmol/L isobutylmethylxanthine (IBMX) present for the first 2 days.9 Subcutaneous abdominal adipose tissue was obtained from 9 patients (4 male, 5 female) undergoing elective abdominal surgery (Ottawa Hospital Research Ethics Committee approval). Human preadipocytes were isolated by collagenase digestion and serial filtrations. Cells were seeded in 24-well plates at 3x104 cells/cm2 in DMEM with 20% FBS, grown to confluence, and then placed in serum-free differentiation medium.10 Differentiation medium was DMEM:Ham’s F12 (1:1), 33 µmol/L biotin, 17 µmol/L pantothenate, 10 µg/mL transferrin, 0.2 nM triiodothyronine, 1 µmol/L insulin, and 1 µmol/L cortisol. For the first 4 days, 0.5 mmol/L IBMX, 25 nM dexamethasone, and 5 µmol/L troglitazone (Roche) were added. The medium was then replaced every 3 days for 2 weeks, and 70% differentiation was observed.

Differentiated 3T3-F442A and 3T3-L1 adipocytes were placed . . . [Full Text of this Article]